In the Face of Adversity: Is Resilience a New Target for Inflammatory Bowel Disease Therapy?

Gastroenterology. 2021 Jan;160(1):466-467. doi: 10.1053/j.gastro.2020.11.023. Epub 2020 Nov 19.

Authors

Keeley M Fairbrass¹, David J Gracie², Alexander C Ford¹

Affiliations

¹ Leeds Gastroenterology Institute; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
² Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.

PMID: 33220251
DOI: 10.1053/j.gastro.2020.11.023

No abstract available

Publication types

Comment

MeSH terms

Humans
Inflammatory Bowel Diseases* / drug therapy
Quality of Life
Resilience, Psychological*